Aug 15 (Reuters) - Shares in Australia's Cochlear
COH.AX sank more than 8% on Thursday, after the hearing
implants maker forecast profit for the current fiscal that fell
short of market expectations.
Cochlear is expecting underlying net profit between A$410
million and A$430 million ($270.15 million and $283.33 million)
for fiscal year 2025, below the Visible Alpha consensus of
A$451.2 million.
Its underlying earnings jumped 27% to A$386.6 million for
the financial year ended June 30, helped by robust performance
across its implants, services and acoustics divisions.
However, it also fell short of Visible Alpha consensus of
A$400.2 million.
Shares in Cochlear, among the priciest in Australia, slumped
8.1% to A$310.260, marking their worst day since late-March
2020.
The stock fell to its lowest since early February this year,
and was among the top five losers in the benchmark index
.AXJO , which was trading around 0.6% higher.
"(COH) stock going to be pressured today given miss to
street and more cautious 6-11% NPAT growth outlook," Macquarie
analysts wrote in a note.
Cochlear announced a final dividend of A$2.10 per share, and
also approved the buyback of up to A$75 million over the next
one year.
The firm had halted its share buyback programme in February,
citing a high interest rate environment.
($1 = 1.5177 Australian dollars)
(Reporting by Sneha Kumar and Sameer Manekar in Bengaluru;
Editing by Rashmi Aich)
((Sneha.Kumar@thomsonreuters.com;))